AJ joins Frederic Laurier and Pierre-Alain Rikkers at Alantra to discuss the lack of transparency and complexity in drug pricing and the oligopolistic PBM industry structure, perpetuating a convoluted reimbursement system. He argues that PBMs exploit the system’s opacity for profit through “casino economics,“ with practices like spread pricing and clawbacks that financially penalize pharmacies, creating inefficiencies and inequities.

Redefining the PBM industry, A Conversation with AJ Loiacono, CEO at Capital Rx

In this episode, Mark Frank, CEO and Co-founder of SonderMind, joins Frederic Laurier, Managing Director at Alantra, to dive into the complexities of the mental health industry. The episode sheds light on SonderMind’s innovative approach of enhancing therapist efficiency and explores how Mark’s diverse background and personal journey have significantly influenced the development of SonderMind. Additionally, the dialogue encompasses the various technological and regulatory hurdles that are currently confronting the mental health sector, emphasizing the necessity for strategic solutions.

Serial Entrepreneur Tackling Mental Health, A Conversation with Mark Frank, CEO and Co-founder at SonderMind

Touching the hottest topic at the moment - Artificial Intelligence - Alfred Whitehead, EVP of Applied Sciences at Klick Consulting, joins Rusty Ray at Alantra to unfold applications in drug commercialization, particularly OTC, and its impact on personalization in marketing and product development.

AI: An Unlimited Army of Interns, A Conversation with Alfred Whitehead at Klick Consulting

In this episode, Rick Froehlich, CEO of ClearDATA, joins Frederic and Michael to discuss the challenges healthcare organizations face in adopting cloud technology, focusing on security concerns surrounding PHI data. The reluctance of providers to migrate due to budget constraints and limited resources creates hurdles for Managed Service Providers. We also highlight ClearDATA’s emergence as a leader in healthcare cybersecurity amid rising threats, offering tailored solutions and a robust CyberHealth Platform.

Protect, Detect & Recover, A Conversation with Rick Froehlich, CEO at ClearDATA

Paul Wardle led switches at HRA Pharma and Pfizer and worked on iconic switch brands such as Viagra, Advil, Lipitor and TUMS. Following up on our last episode on Rx-to-OTC Switches, Paul sheds lights on ACNU - the FDA's proposed rule on non-prescription drug products with additional conditions for non-prescriptive use. This is the FDA's 12-year effort in the works, aiming to empower consumers, foster stakeholder collaboration, and redefine access based on individual characteristics.

Non-Rx Drug Access - ACNU, a Conversation with Paul Wardle

Explore the transformative journey of PointClickCare, a healthcare technology trailblazer inspired by Salesforce's success mantra. Overcoming skepticism, the company pioneered a seamless Software as a Service (SaaS) model in post-acute care, serving thousands of facilities. Strategic acquisitions and recent ventures, including Patient Pattern, demonstrate their commitment to innovative healthcare solutions in an evolving landscape. Mike Wessinger, Co-Founder of PointClickCare, joins Frederic Laurier at Alantra to discuss the growth journey of the company.

A HealthTech Pioneer, A Conversation with Mike Wessinger at PointClickCare

Paul Wardle led switches at HRA Pharma and Pfizer and worked on iconic switch brands such as Viagra, Advil, Lipitor and Opill. In light of recent Rx-to-OTC switches, Paul, who is now founder at Beacon Associates, shares his perspectives from his decade-long switch experience. In this episode, Rusty and Paul discussed the underlying impacts switch products bring to consumer adherence and utilization, as well as the switch process and the new ACNU regulation.

Rx-to-OTC Switch Challenges and Opportunities, a Conversation with Paul Wardle, Founder of Beacon Associates

Collaboration between payers and providers has not only technological but also behavioral roadblocks. Dan Wilson, Founder & CEO of Moxe Health, joins Frederic Laurier at Alantra to discuss overcoming historical trust issues between the two, how he has built a purely digital business in a historically services-oriented Release of Information (ROI) subsector, the Datavant / Ciox merger, his provider subsidization model, and the importance of fast implementations in healthcare IT.

Efficiently Breaking Barriers Between Payers and Providers with Dan Wilson, CEO at Moxe Health

The concept of scoring and normalizing health assessments, similar to FICO in FinTech, is being explored to establish a global standard for health. Peter Ohnemus, serial entrepreneur and CEO & Founder of Dacadoo, joins Alantra to discuss how his design for digital health assessments aids dynamic pricing for Life & Health Insurance, and the importance of digital health engagement in a member's lifetime.

Managing Health of a Lifetime, a Conversation with Peter Ohnemus, CEO at Dacadoo

Healthcare data as we know it today is siloed. Ardy Arianpour, CEO & Co-Founder of SEQSTER, joins Frederic Laurier at Alantra to discuss data refinement, standardization, and tokenization to pull various data sources into one place, how a digital front door impacts clinical trial dropout rates, and opportunities to incorporate other sources of medical data in the future.

Building a Healthcare OS, A Conversation with Ardy Arianpour, CEO at SEQSTER

Join Crossroads by Alantra, where our global experts discuss the global trends and what they mean for your investment portfolio or business.

Alantra is an international financial services firm providing investment banking and alternative asset management services to corporations, family-owned companies, and institutional investors.. Find out more > Alantra | Possibility is in the ascent [https://www.alantra.com/]